Ex Parte QUIS et al - Page 10



         Appeal No. 2005-0359                                                        
         Application No. 09/333,917                                                  

         amounts of C2-C4 (meth)acrylates, C5 or higher (meth)acrylates,             
         and polyfunctional (meth)acrylates are limited to 20% by wt.,               
         15% by wt., and 10% by wt., respectively.  (Id.)  This position             
         lacks merit.  Our reviewing court has explained that the “case              
         law does not require that a particular combination must be the              
         preferred, or the most desirable, combination described in the              
         prior art in order to provide the motivation for the current                
         invention.”  In re Fulton, 391 F.3d 1995, 1200, 73 USPQ2d 1141,             
         1145 (Fed. Cir. 2004).  Rather, the court has instructed:                   
              “[T]he question is whether there is something in the                   
              prior art as a whole to suggest the desirability, and                  
              thus the obviousness, of making the combination,” not                  
              whether there is something in the prior art as a whole                 
              to suggest that the combination is the most desirable                  
              combination available.                                                 
         Id. (quoting In re Beattie, 974 F.2d 1309, 1311, 21 USPQ2d 1040,            
         1042 (Fed. Cir. 1992); accord In re Gurley, 27 F.3d 551, 552-53,            
         31 USPQ2d 1130, 1132 (Fed. Cir. 1994)(“A known or obvious                   
         composition does not become patentable simply because it has                
         been described as somewhat inferior.”).                                     
              Relying on the data presented in Table 1 of the present                
         specification (page 26), the appellants urge that compositions              
         “containing less than the requisite total amount of paraffin and            
         1,4-butanediol dimethacrylate (1,4-BDMA) results in poor curing,            

                                         10                                          


Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next 

Last modified: November 3, 2007